Методика за оценка влиянието на изменението на референтната стойност на лекарствените продукти, включени в плс върху стойността, заплащана от НЗОК
Methodology for the assessment of the changes in the reference value of the medicinal products on the value paid by the NHIF

Author(s): Silvia Terezova
Subject(s): Economy
Published by: Икономически университет - Варна
Keywords: reference value; reimbursement; reference pricing; Positive List; National Health Insurance Fund (NHIF)
Summary/Abstract: The prices regulation of the medicinal products included in Positive Drug List affects the reference value for the DDD/ treatment course. The National Health Insurance Fund (NHIF) pays the pharmaceutical products at the value of the final pack, calculated on the basis of the lowest reference value and the reimbursement rate. These changes therefore affect the cost of a public resource. The reference value changes are very dynamic as a result of medicinal products prices changes. These changes are the result of external and internal reference pricing of the medicinal products included in Positive List. It is the dynamics in changes of the reference value that determines the necessity to create a methodology for assessing its impact on the value paid by NHIF.

• Details
• Contents